Dan Hurren

I'm not sure you actually gave us your thoughts on what you think the range of outcomes will be

can you just talk through the elements of that gross margin guidance? And maybe touch on the FX

I was just wondering if that exemption will apply or extend to all CPAP and therapy coming into the US

Can you just talk us through any other FX impacts down the P&L as we've seen the strength of the U.S. dollar?

we've noticed that this term tuck-in acquisition has become very common in your commentary